Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary ...

Retrieved on: 2025-10-14 15:44:03

Tags for this article:

Cognitive disorders

Learning disabilities

Alzheimer's disease

Aging-associated diseases

Dementia

Roche

Mild cognitive impairment

Biomarker

Roche Group

Click the tags to see associated articles and topics

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary .... View article details on hiswai:

Excerpt

INDIANAPOLIS, Oct. 13, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration ( ...

Article found on: www.biospace.com

View Original Article